妊娠检测试剂盒市场机会、成长动力、产业趋势分析及 2025-2034 年预测

2024 年全球妊娠检测试剂盒市场价值为 17 亿美元，预计 2025 年至 2034 年的复合年增长率为 5.4%。这些试剂盒透过识别尿液或血液样本中的人类绒毛膜促性腺激素 (hCG) 来帮助检测怀孕。它们无需医疗监督即可提供快速的结果，是一种方便的选择。越来越多的人选择早期检测，即在月经延迟前发现怀孕，这是一个关键的成长因素。这些测试可以快速确认，从而实现及时的产前护理、更好地管理高风险妊娠以及做出明智的决策。大多数声称准确率高达 99%，增强了消费者信心。

根据产品，市场分为有线妊娠测试、数位设备和其他选择。 Line 妊娠测试引领市场，2024 年产值达 8.897 亿美元。其价格实惠、方便易得且易于使用，使其成为首选。这些测试可在药局和网路上进行，透过检测尿液样本中的 hCG 提供即时结果。

根据测试类型，市场包括 hCG 尿液测试和 hCG 血液检查。 2024 年，尿液检测部分占市场收入的 63.5%，预计到 2034 年将达到 18 亿美元。尿液检测之所以受到青睐，是因为其非侵入性、价格实惠且易于使用。这些测试有试纸、盒式和中游式三种形式，使用者可以根据方便进行选择。虽然试纸测试需要浸泡尿液样本，但盒式和中段测试省去了这一步骤，增强了用户体验。

根据配销通路，市场分为网路药局、医院药局和零售药局。 2024 年，医院药局的收入最高，为 9.173 亿美元。消费者通常更喜欢从医院药房购买妊娠检测试剂盒，因为那里有训练有素的医疗专业人员，可以确保指导和可靠性。超音波成像和血液测试等额外医院服务的提供进一步推动了需求。

从地区来看，北美是市场成长的主要贡献者。预计到 2034 年，美国妊娠检测试剂盒市场规模将达到 10 亿美元。高达 99% 的女性识​​字率提高了怀孕检测意识，从而推动了家庭检测选项的需求。此外，强大的美国医疗保健体系支持计划生育倡议，并透过零售和电子商务管道广泛提供妊娠试剂盒，从而推动市场扩张。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 女性识字率不断提高
    • 快速妊娠诊断的技术进步
    • 家庭检测解决方案的需求不断增长
    • 更重视早期妊娠检测
  • 产业陷阱与挑战
    • 早期检测的准确性问题
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 妊娠试验线
• 数位装置
• 其他产品

第六章：市场估计与预测：按测试类型，2021 年至 2034 年

• 主要趋势
• 尿液HCG检测
• 血液HCG检测

第七章：市场估计与预测：按配销通路，2021 年至 2034 年

• 主要趋势
• 医院药房
• 网路药局
• 零售药局

第八章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第九章：公司简介

• Abbott Laboratories
• Cardinal Health
• Church & Dwight
• Danaher Corporation
• McKesson Corporation
• Medline Industries, LP.
• Meridian Bioscience, Inc.
• QuidelOrtho Corporation
• Rapigen
• SEKISUI CHEMICAL CO., LTD.
• SPD Swiss Precision Diagnostics GmbH
• Thermo Fisher Scientific

The Global Pregnancy Detection Kits Market was valued at USD 1.7 billion in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2034. These kits help detect pregnancy by identifying human chorionic gonadotropin (hCG) in urine or blood samples. They provide fast results without requiring medical supervision, making them a convenient option. Increasing preference for early detection tests, which identify pregnancy before a missed period, is a key growth factor. These tests offer quick confirmation, allowing timely prenatal care, better management of high-risk pregnancies, and informed decision-making. Most claim 99% accuracy, reinforcing consumer confidence.

By product, the market is divided into line pregnancy tests, digital devices, and other options. Line pregnancy tests led the market, generating USD 889.7 million in 2024. Their affordability, accessibility, and ease of use make them a top choice. These tests, available in pharmacies and online, provide instant results by detecting hCG in urine samples.

Based on test type, the market includes urine tests for hCG and blood tests for hCG. The urine test segment accounted for 63.5% of market revenue in 2024 and is anticipated to reach USD 1.8 billion by 2034. The preference for urine tests stems from their non-invasive nature, affordability, and ease of use. These tests come in strip, cassette, and midstream formats, allowing users to choose based on convenience. While strip tests require dipping in a urine sample, cassette and midstream versions eliminate this step, enhancing user experience.

By distribution channel, the market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. Hospital pharmacies generated the highest revenue of USD 917.3 million in 2024. Consumers often prefer purchasing pregnancy detection kits from hospital pharmacies due to the presence of trained medical professionals, ensuring guidance and reliability. The availability of additional hospital services, such as ultrasound imaging and blood tests, further drives demand.

Regionally, North America is a major contributor to market growth. The US pregnancy detection kits market is set to reach USD 1 billion by 2034. A high women literacy rate of 99% has increased awareness of pregnancy detection, boosting demand for home testing options. Additionally, the strong US healthcare system supports family planning initiatives and provides broad accessibility to pregnancy kits through retail and e-commerce channels, driving market expansion.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising literacy rates among women
    • 3.2.1.2 Technological advancements in rapid pregnancy diagnostics
    • 3.2.1.3 Increasing demand for at-home testing solutions
    • 3.2.1.4 Enhanced emphasis on early pregnancy detection
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Accuracy concerns in early detection
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Line pregnancy tests
• 5.3 Digital devices
• 5.4 Other products

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Urine test for HCG
• 6.3 Blood test for HCG

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospital pharmacies
• 7.3 Online pharmacies
• 7.4 Retail pharmacies

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Cardinal Health
• 9.3 Church & Dwight
• 9.4 Danaher Corporation
• 9.5 McKesson Corporation
• 9.6 Medline Industries, LP.
• 9.7 Meridian Bioscience, Inc.
• 9.8 QuidelOrtho Corporation
• 9.9 Rapigen
• 9.10 SEKISUI CHEMICAL CO., LTD.
• 9.11 SPD Swiss Precision Diagnostics GmbH
• 9.12 Thermo Fisher Scientific